{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Gynecological cancers", "cervical cancer", "endometrial/uterine cancer", "half life.", "nanoplatforms", "ovarian cancer"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38500284", "DateCompleted": {"Year": "2024", "Month": "06", "Day": "20"}, "DateRevised": {"Year": "2024", "Month": "06", "Day": "25"}, "Article": {"Language": ["eng"], "ELocationID": ["10.2174/0113816128291955240306112558"], "ArticleDate": [], "Journal": {"ISSN": "1873-4286", "JournalIssue": {"Volume": "30", "Issue": "13", "PubDate": {"Year": "2024"}}, "Title": "Current pharmaceutical design", "ISOAbbreviation": "Curr Pharm Des"}, "ArticleTitle": "The Application of Nanotechnological Therapeutic Platforms against Gynecological Cancers.", "Pagination": {"StartPage": "975", "EndPage": "987", "MedlinePgn": "975-987"}, "Abstract": {"AbstractText": ["Gynecological cancers (GCs), ovarian, cervical, and endometrial/uterine cancers, are often associated with poor outcomes. Despite the development of several therapeutic modalities against GCs, the effectiveness of the current therapeutic approaches is limited due to their side effects, low therapeutic index, short halflife, and resistance to therapy. To overcome these limitations, nano delivery-based approaches have been introduced with the potential of targeted delivery, reduced toxicity, controlled release, and improved bioavailability of various cargos. This review summarizes the application of different nanoplatforms, such as lipid-based, metal- based, and polymeric nanoparticles, to improve the chemo/radio treatments of GC. In the following work, the use of nanoformulated agents to fight GCs has been mentioned in various clinical trials. Although nanosystems have their own challenges, the knowledge highlighted in this article could provide deep insight into translations of NPs approaches to overcome GCs."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Keyvani", "ForeName": "Vahideh", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Mollazadeh", "ForeName": "Samaneh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Blood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR), Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Department of Biology, Islamic Azad University, Mashhad Branch, Mashhad, Iran."}], "LastName": "Riahi", "ForeName": "Espanta", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Mahmoudian", "ForeName": "Reihaneh Alsadat", "Initials": "RA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Tabari", "ForeName": "Masoomeh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Lagzian", "ForeName": "Elmira", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Ghorbani", "ForeName": "Elnaz", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Akbarzade", "ForeName": "Hamed", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Gholami", "ForeName": "Amir-Sadra", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq."}], "LastName": "Gataa", "ForeName": "Ibrahim Saeed", "Initials": "IS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Hassanian", "ForeName": "Seyed Mahdi", "Initials": "SM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Medical Education, Brighton & Sussex Medical School, Falmer, Brighton, Sussex BN1 9PH, UK."}], "LastName": "Ferns", "ForeName": "Gordon A", "Initials": "GA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Khazaei", "ForeName": "Majid", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT), Brisbane 4059, Australia."}], "LastName": "Avan", "ForeName": "Amir", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Anvari", "ForeName": "Kazem", "Initials": "K"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Pharm Des", "NlmUniqueID": "9602487", "ISSNLinking": "1381-6128"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Genital Neoplasms, Female"}, {"QualifierName": ["pharmacology", "chemistry", "administration & dosage"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nanoparticles"}, {"QualifierName": [], "DescriptorName": "Nanotechnology"}, {"QualifierName": [], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": [], "DescriptorName": "Animals"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Keyvani V.; Kheradmand N.; Navaei Z.N.; Mollazadeh S.; Esmaeili S.A.; Epidemiological trends and risk factors of gynecological cancers: An update. Med Oncol 2023,40(3),93", "ArticleIdList": ["10.1007/s12032-023-01957-3", "36757546"]}, {"Citation": "Keyvani V.; Riahi E.; Yousefi M.; Esmaeili S.A.; Shafabakhsh R.; Moradi Hasan-Abad A.; Mahjoubin-Tehran M.; Hamblin M.R.; Mollazadeh S.; Mirzaei H.; Gynecologic cancer, cancer stem cells, and possible targeted therapies. Front Pharmacol 2022,13,823572", "ArticleIdList": ["10.3389/fphar.2022.823572", "35250573"]}, {"Citation": "Piechocki M.; Kozio\u0142ek W.; Sroka D.; Matrejek A.; Mizio\u0142ek P.; Saiuk N.; Sledzik M.; Jaworska A.; Bereza K.; Pluta E.; Banas T.; Trends in incidence and mortality of gynecological and breast cancers in Poland (1980-2018). Clin Epidemiol 2022,14,95-114", "ArticleIdList": ["10.2147/CLEP.S330081", "35115839"]}, {"Citation": "Gultekin M.; Dundar S.; Kucukyildiz I.; Karaca M.Z.; Boztas G.; Turan S.H.; Hacikamiloglu E.; Keskinkilic B.; Survival of gynecological cancers in Turkey: Where are we at? J Gynecol Oncol 2017,28(6),e85", "ArticleIdList": ["10.3802/jgo.2017.28.e85", "29027403"]}, {"Citation": "Wang Q.; Peng H.; Qi X.; Wu M.; Zhao X.; Targeted therapies in gynecological cancers: A comprehensive review of clinical evidence. Signal Transduct Target Ther 2020,5(1),137", "ArticleIdList": ["10.1038/s41392-020-0199-6", "32728057"]}, {"Citation": "Bejar F.G.; Oaknin A.; Williamson C.; Mayadev J.; Peters P.N.; Secord A.A.; Wield A.M.; Coffman L.G.; Novel therapies in gynecologic cancer. Am Soc Clin Oncol Educ Book 2022,42,1-17", "ArticleIdList": ["35594502"]}, {"Citation": "Zheng F.; Xiong W.; Sun S.; Zhang P.; Zhu J.J.; Recent advances in drug release monitoring. Nanophotonics 2019,8(3),391-413", "ArticleIdList": ["10.1515/nanoph-2018-0219"]}, {"Citation": "Wang T.; Jiang K.; Wang Y.; Xu L.; Liu Y.; Zhang S.; Xiong W.; Wang Y.; Zheng F.; Zhu J-J.; Prolonged near-infrared fluorescence imaging of microRNAs and proteases in vivo by aggregation-enhanced emission from DNA-AuNC nanomachines. Chem Sci 2024,15(5),1829-1839", "ArticleIdList": ["10.1039/D3SC05887E", "38303939"]}, {"Citation": "Malik A; Tahir Butt T; Zahid S; Use of magnetic nanoparticles as targeted therapy: Theranostic approach to treat and diagnose cancer. J Nanotechnol 2017,2017,1-8", "ArticleIdList": ["10.1155/2017/1098765"]}, {"Citation": "Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R; Nanocarriers as an emerging platform for cancer therapy 2020,61-91", "ArticleIdList": ["10.1201/9780429399039-2"]}, {"Citation": "Liu S.; Cheng Q.; Wei T.; Yu X.; Johnson L.T.; Farbiak L.; Siegwart D.J.; Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR- Cas gene editing. Nat Mater 2021,20(5),701-710", "ArticleIdList": ["10.1038/s41563-020-00886-0", "33542471"]}, {"Citation": "Min Y.; Caster J.M.; Eblan M.J.; Wang A.Z.; Clinical translation of nanomedicine. Chem Rev 2015,115(19),11147-11190", "ArticleIdList": ["10.1021/acs.chemrev.5b00116", "26088284"]}, {"Citation": "Yang T.; Zhai J.; Hu D.; Yang R.; Wang G.; Li Y.; Liang G.; \u201cTargeting design\u201d of nanoparticles in tumor therapy. Pharmaceutics 2022,14(9),1919", "ArticleIdList": ["10.3390/pharmaceutics14091919", "36145668"]}, {"Citation": "Dutta B.; Nema A.; Shetake N.G.; Gupta J.; Barick K.C.; Lawande M.A.; Pandey B.N.; Priyadarsini I.K.; Hassan P.A.; Glutamic acid-coated FeO nanoparticles for tumor-targeted imaging and therapeutics. Mater Sci Eng C 2020,112,110915", "ArticleIdList": ["10.1016/j.msec.2020.110915", "32409067"]}, {"Citation": "Cheng Z.; Li M.; Dey R.; Chen Y.; Nanomaterials for cancer therapy: Current progress and perspectives. J Hematol Oncol 2021,14(1),85", "ArticleIdList": ["10.1186/s13045-021-01096-0", "34059100"]}, {"Citation": "Mare R.; Paolino D.; Celia C.; Molinaro R.; Fresta M.; Cosco D.; Post-insertion parameters of PEG-derivatives in phosphocholine-liposomes. Int J Pharm 2018,552(1-2),414-421", "ArticleIdList": ["10.1016/j.ijpharm.2018.10.028", "30316001"]}, {"Citation": "Qi Z.; Yin L.; Xu Y.; Wang F.; Pegylated liposomal-paclitaxel induces ovarian cancer cell apoptosis via TNF-induced ERK/AKT signaling pathway. Mol Med Rep 2018,17(6),7497-7504", "ArticleIdList": ["10.3892/mmr.2018.8811", "29620264"]}, {"Citation": "Krieger M.L.; Eckstein N.; Schneider V.; Koch M.; Royer H.D.; Jaehde U.; Bendas G.; Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro. Int J Pharm 2010,389(1-2),10-17", "ArticleIdList": ["10.1016/j.ijpharm.2009.12.061", "20060458"]}, {"Citation": "Shaikh I.M.; Tan K.B.; Chaudhury A.; Liu Y.; Tan B.J.; Tan B.M.J.; Chiu G.N.C.; Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft. J Control Release 2013,172(3),852-861", "ArticleIdList": ["10.1016/j.jconrel.2013.10.025", "24459693"]}, {"Citation": "Turk M.J.; Waters D.J.; Low P.S.; Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. Cancer Lett 2004,213(2),165-172", "ArticleIdList": ["10.1016/j.canlet.2003.12.028", "15327831"]}, {"Citation": "Karimi M.; Ghasemi A.; Sahandi Zangabad P.; Rahighi R.; Moosavi Basri S.M.; Mirshekari H.; Amiri M.; Shafaei Pishabad Z.; Aslani A.; Bozorgomid M.; Ghosh D.; Beyzavi A.; Vaseghi A.; Aref A.R.; Haghani L.; Bahrami S.; Hamblin M.R.; Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem Soc Rev 2016,45(5),1457-1501", "ArticleIdList": ["10.1039/C5CS00798D", "26776487"]}, {"Citation": "Subhan M.A.; Yalamarty S.S.K.; Filipczak N.; Parveen F.; Torchilin V.P.; Recent advances in tumor targeting via EPR effect for cancer treatment. J Pers Med 2021,11(6),571", "ArticleIdList": ["10.3390/jpm11060571", "34207137"]}, {"Citation": "Hamdy N.M.; Eskander G.; Basalious E.B.; Insights on the dynamic innovative tumor targeted-nanoparticles-based drug delivery systems activation techniques. Int J Nanomed 2022,17,6131-6155", "ArticleIdList": ["10.2147/IJN.S386037", "36514378"]}, {"Citation": "Overchuk M.; Zheng G.; Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics. Biomaterials 2018,156,217-237", "ArticleIdList": ["10.1016/j.biomaterials.2017.10.024", "29207323"]}, {"Citation": "Shen Z.; Chen T.; Ma X.; Ren W.; Zhou Z.; Zhu G.; Zhang A.; Liu Y.; Song J.; Li Z.; Ruan H.; Fan W.; Lin L.; Munasinghe J.; Chen X.; Wu A.; Multifunctional theranostic nanoparticles based on exceedingly small magnetic iron oxide nanoparticles for T 1-weighted magnetic resonance imaging and chemotherapy. ACS Nano 2017,11(11),10992-11004", "ArticleIdList": ["10.1021/acsnano.7b04924", "29039917"]}, {"Citation": "Sanna V.; Sechi M.; Therapeutic potential of targeted nanoparticles and perspective on nanotherapies. ACS Med Chem Lett 2020,11(6),1069-1073", "ArticleIdList": ["10.1021/acsmedchemlett.0c00075", "32550978"]}, {"Citation": "Zhao X.; Yang C.X.; Chen L.G.; Yan X.P.; Dual-stimuli responsive and reversibly activatable theranostic nanoprobe for precision tumor-targeting and fluorescence-guided photothermal therapy. Nat Commun 2017,8(1),14998", "ArticleIdList": ["10.1038/ncomms14998", "28524865"]}, {"Citation": "Zhang J.; Lin Y.; Lin Z.; Wei Q.; Qian J.; Ruan R.; Jiang X.; Hou L.; Song J.; Ding J.; Yang H.; Stimuli-responsive nanoparticles for controlled drug delivery in synergistic cancer immunotherapy. Adv Sci 2022,9(5),2103444", "ArticleIdList": ["10.1002/advs.202103444", "34927373"]}, {"Citation": "Shi J.; Kantoff P.W.; Wooster R.; Farokhzad O.C.; Cancer nanomedicine: Progress, challenges and opportunities. Nat Rev Cancer 2017,17(1),20-37", "ArticleIdList": ["10.1038/nrc.2016.108", "27834398"]}, {"Citation": "Shi J.; Xiao Z.; Kamaly N.; Farokhzad O.C.; Self-assembled targeted nanoparticles: Evolution of technologies and bench to bedside translation. Acc Chem Res 2011,44(10),1123-1134", "ArticleIdList": ["10.1021/ar200054n", "21692448"]}, {"Citation": "Nsairat H.; Khater D.; Sayed U.; Odeh F.; Al Bawab A.; Alshaer W.; Liposomes: Structure, composition, types, and clinical applications. Heliyon 2022,8(5),e09394", "ArticleIdList": ["10.1016/j.heliyon.2022.e09394", "35600452"]}, {"Citation": "Chauhan I.; Yasir M.; Verma M.; Singh A.P.; Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery. Adv Pharm Bull 2020,10(2),150-165", "ArticleIdList": ["10.34172/apb.2020.021", "32373485"]}, {"Citation": "Michy T.; Massias T.; Bernard C.; Vanwonterghem L.; Henry M.; Guidetti M.; Royal G.; Coll J.L.; Texier I.; Josserand V.; Hurbin A.A.; Verteporfin-loaded lipid nanoparticles improve ovarian cancer photodynamic therapy in vitro and in vivo. Cancers (Basel) 2019,11(11),1760", "ArticleIdList": ["10.3390/cancers11111760", "31717427"]}, {"Citation": "Han S.; Dwivedi P.; Mangrio F.A.; Dwivedi M.; Khatik R.; Cohn D.E.; Si T.; Xu R.X.; Sustained release paclitaxel-loaded core-shell-structured solid lipid microparticles for intraperitoneal chemotherapy of ovarian cancer. Artif Cells Nanomed Biotechnol 2019,47(1),957-967", "ArticleIdList": ["10.1080/21691401.2019.1576705", "30892967"]}, {"Citation": "Hanafy N.; El-Kemary M.; Leporatti S.; Micelles structure development as a strategy to improve smart cancer therapy. Cancers 2018,10(7),238", "ArticleIdList": ["10.3390/cancers10070238", "30037052"]}, {"Citation": "Zhu L.; Torchilin V.P.; Stimulus-responsive nanopreparations for tumor targeting. Integr Biol 2013,5(1),96-107", "ArticleIdList": ["10.1039/c2ib20135f", "22869005"]}, {"Citation": "Mutlu-Agardan N.B.; Sarisozen C.; Torchilin V.P.; Cytotoxicity of novel redox sensitive PEG 2000-SS-PTX micelles against drug-resistant ovarian and breast cancer cells. Pharm Res 2020,37(3),65", "ArticleIdList": ["10.1007/s11095-020-2759-4", "32166361"]}, {"Citation": "Li G.; Xu W.; Shi Y.; Chen M.; Peng D.; Construction of a new dual-responsive nano-drug delivery system for matrix metalloproteinases and adenosine triphosphate in ovarian cancer using nanomicelles. J Biomed Nanotechnol 2022,18(3),718-728", "ArticleIdList": ["10.1166/jbn.2022.3303", "35715904"]}, {"Citation": "Kazemi M.; Emami J.; Hasanzadeh F.; Minaiyan M.; Mirian M.; Lavasanifar A.; Pegylated multifunctional pH-responsive targeted polymeric micelles for ovarian cancer therapy: Synthesis, characterization and pharmacokinetic study. Int J Polym Mater 2021,70(14),1012-1026", "ArticleIdList": ["10.1080/00914037.2020.1776282"]}, {"Citation": "Wu Y.; Lv S.; Li Y.; He H.; Ji Y.; Zheng M.; Liu Y.; Yin L.; Co-delivery of dual chemo-drugs with precisely controlled, high drug loading polymeric micelles for synergistic anti-cancer therapy. Biomater Sci 2020,8(3),949-959", "ArticleIdList": ["10.1039/C9BM01662G", "31840696"]}, {"Citation": "Groo A.C.; Hedir S.; Since M.; Brotin E.; Weiswald L.B.; Paysant H.; Nee G.; Coolzaet M.; Goux D.; Del\u00e9p\u00e9e R.; Freret T.; Poulain L.; Voisin-Chiret A.S.; Malzert-Fr\u00e9on A.; Pyridoclax-loaded nanoemulsion for enhanced anticancer effect on ovarian cancer. Int J Pharm 2020,587,119655", "ArticleIdList": ["10.1016/j.ijpharm.2020.119655", "32712252"]}, {"Citation": "Ganta S.; Singh A.; Patel N.R.; Cacaccio J.; Rawal Y.H.; Davis B.J.; Amiji M.M.; Coleman T.P.; Development of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancer. Pharm Res 2014,31(9),2490-2502", "ArticleIdList": ["10.1007/s11095-014-1345-z", "24643932"]}, {"Citation": "Sahib Abed H.; Zarearki P.; Khojasteh V.; Karimi E.; Shahrokhabadi K.; Rastegar Moghaddam Poorbagher M.; Inhibition the growth of human ovarian cancer cells (A2780) via cell proliferation and angiogenesis by viola odorata essential oil nanoemulsion. Waste Biomass Valoriz 2023,1-10", "ArticleIdList": ["10.1007/s12649-023-02314-1"]}, {"Citation": "Zheng N.; Gao Y.; Ji H.; Wu L.; Qi X.; Liu X.; Tang J.; Vitamin E derivative-based multifunctional nanoemulsions for overcoming multidrug resistance in cancer. J Drug Target 2016,24(7),663-669", "ArticleIdList": ["10.3109/1061186X.2015.1135335", "26710274"]}, {"Citation": "Sharma A.R.; Lee Y.H.; Bat-Ulzii A.; Bhattacharya M.; Chakraborty C.; Lee S.S.; Recent advances of metal-based nanoparticles in nucleic acid delivery for therapeutic applications. J Nanobiotechnol 2022,20(1),501", "ArticleIdList": ["10.1186/s12951-022-01650-z", "36434667"]}, {"Citation": "Taheri-Ledari R.; Zolfaghari E.; Zarei-Shokat S.; Kashtiaray A.; Maleki A.; A magnetic antibody-conjugated nano-system for selective delivery of Ca(OH) and taxotere in ovarian cancer cells. Commun Biol 2022,5(1),995", "ArticleIdList": ["10.1038/s42003-022-03966-w", "36130999"]}, {"Citation": "Ma X.; Zhou W.; Zhang R.; Zhang C.; Yan J.; Feng J.; Rosenholm J.M.; Shi T.; Shen X.; Zhang H.; Minimally invasive injection of biomimetic Nano@Microgel for in situ ovarian cancer treatment through enhanced photodynamic reactions and photothermal combined therapy. Mater Today Bio 2023,20,100663", "ArticleIdList": ["10.1016/j.mtbio.2023.100663", "37273798"]}, {"Citation": "Sharma A.K.; Gothwal A.; Kesharwani P.; Alsaab H.; Iyer A.K.; Gupta U.; Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery. Drug Discov Today 2017,22(2),314-326", "ArticleIdList": ["10.1016/j.drudis.2016.09.013", "27671487"]}, {"Citation": "Wang J.; Li B.; Qiu L.; Qiao X.; Yang H.; Dendrimer-based drug delivery systems: History, challenges, and latest developments. J Biol Eng 2022,16(1),18", "ArticleIdList": ["10.1186/s13036-022-00298-5", "35879774"]}, {"Citation": "Janaszewska A.; Lazniewska J.; Trzepi\u0144ski P.; Marcinkowska M.; Klajnert-Maculewicz B.; Cytotoxicity of dendrimers. Biomolecules 2019,9(8),330", "ArticleIdList": ["10.3390/biom9080330", "31374911"]}, {"Citation": "Cai L.; Xu G.; Shi C.; Guo D.; Wang X.; Luo J.; Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment. Biomaterials 2015,37,456-468", "ArticleIdList": ["10.1016/j.biomaterials.2014.10.044", "25453973"]}, {"Citation": "Cruz A.; Mota P.; Ramos C.; Pires R.F.; Mendes C.; Silva J.P.; Nunes S.C.; Bonif\u00e1cio V.D.B.; Serpa J.; Polyurea dendrimer folate-targeted nanodelivery of l-buthionine sulfoximine as a tool to tackle ovarian cancer chemoresistance. Antioxidants 2020,9(2),133", "ArticleIdList": ["10.3390/antiox9020133", "32028640"]}, {"Citation": "Kothamasu P.; Kanumur H.; Ravur N.; Maddu C.; Parasuramrajam R.; Thangavel S.; Nanocapsules: The weapons for novel drug delivery systems. Bioimpacts 2012,2(2),71-81", "ArticleIdList": ["23678444"]}, {"Citation": "Haggag Y.A.; Ibrahim R.R.; Hafiz A.A.; Design, formulation and in vivo evaluation of novel honokiol-loaded PEGylated PLGA nanocapsules for treatment of breast cancer. Int J Nanomed 2020,15,1625-1642", "ArticleIdList": ["10.2147/IJN.S241428", "32210557"]}, {"Citation": "Wang J.T.W.; Spinato C.; Klippstein R.; Costa P.M.; Martincic M.; Pach E.; Ruiz de Garibay A.P.; M\u00e9nard-Moyon C.; Feldman R.; Michel Y.; \u0160efl M.; Kyriakou I.; Emfietzoglou D.; Saccavini J-C.; Ballesteros B.; Tobias G.; Bianco A.; Al-Jamal K.T.; Neutron-irradiated antibody-functionalised carbon nanocapsules for targeted cancer radiotherapy. Carbon 2020,162,410-422", "ArticleIdList": ["10.1016/j.carbon.2020.02.060"]}, {"Citation": "Staffhorst R.W.H.M.; van der Born K.; Erkelens C.A.M.; Hamelers I.H.L.; Peters G.J.; Boven E.; de Kroon A.I.P.M.; Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts. Anticancer Drugs 2008,19(7),721-727", "ArticleIdList": ["10.1097/CAD.0b013e328304355f", "18594214"]}, {"Citation": "Vergara D.; Bellomo C.; Zhang X.; Vergaro V.; Tinelli A.; Lorusso V.; Rinaldi R.; Lvov Y.M.; Leporatti S.; Maffia M.; Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer. Nanomedicine 2012,8(6),891-899", "ArticleIdList": ["10.1016/j.nano.2011.10.014", "22100754"]}, {"Citation": "Alizadeh L.; Alizadeh E.; Zarebkohan A.; Ahmadi E.; Rahmati-Yamchi M.; Salehi R.; AS1411 aptamer-functionalized chitosan-silica nanoparticles for targeted delivery of epigallocatechin gallate to the SKOV-3 ovarian cancer cell lines. J Nanopart Res 2020,22(1),5", "ArticleIdList": ["10.1007/s11051-019-4735-7"]}, {"Citation": "\u0130nce \u0130.; Y\u0131ld\u0131r\u0131m Y.; G\u00fcler G.; Medine E.\u0130.; Ball\u0131ca G.; Ku\u015fdemir B.C.; G\u00f6ker E.; Synthesis and characterization of folic acid-chitosan nanoparticles loaded with thymoquinone to target ovarian cancer cells. J Radioanal Nucl Chem 2020,324(1),71-85", "ArticleIdList": ["10.1007/s10967-020-07058-z"]}, {"Citation": "Fraguas-S\u00e1nchez A.I.; Torres-Su\u00e1rez A.I.; Cohen M.; Delie F.; Bastida-Ruiz D.; Yart L.; Martin-Sabroso C.; Fern\u00e1ndez-Carballido A.; PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: In vitro and in ovo assessment. Pharmaceutics 2020,12(5),439", "ArticleIdList": ["10.3390/pharmaceutics12050439", "32397428"]}, {"Citation": "S\u00e1nchez-Ram\u00edrez D.R.; Dom\u00ednguez-R\u00edos R.; Ju\u00e1rez J.; Vald\u00e9s M.; Hassan N.; Quintero-Ramos A.; del Toro-Arreola A.; Barbosa S.; Taboada P.; Topete A.; Daneri-Navarro A.; Biodegradable photoresponsive nanoparticles for chemo-, photothermal- and photodynamic therapy of ovarian cancer. Mater Sci Eng C 2020,116,111196", "ArticleIdList": ["10.1016/j.msec.2020.111196", "32806317"]}, {"Citation": "Song M.; Fang Z.; Wang J.; Liu K.; A nano-targeted co-delivery system based on gene regulation and molecular blocking strategy for synergistic enhancement of platinum chemotherapy sensitivity in ovarian cancer. Int J Pharm 2023,640,123022", "ArticleIdList": ["10.1016/j.ijpharm.2023.123022", "37156306"]}, {"Citation": "Wang Z.; Guo B.; Yue S.; Zhao S.; Meng F.; Zhong Z.; HER-2-mediated nano-delivery of molecular targeted drug potently suppresses orthotopic epithelial ovarian cancer and metastasis. Int J Pharm 2022,625,122126", "ArticleIdList": ["10.1016/j.ijpharm.2022.122126", "35995316"]}, {"Citation": "Dana P.; Bunthot S.; Suktham K.; Surassmo S.; Yata T.; Namdee K.; Yingmema W.; Yimsoo T.; Ruktanonchai U.R.; Sathornsumetee S.; Saengkrit N.; Active targeting liposome- PLGA composite for cisplatin delivery against cervical cancer. Colloids Surf B Biointerfaces 2020,196,111270", "ArticleIdList": ["10.1016/j.colsurfb.2020.111270", "32777659"]}, {"Citation": "Wang L.; Liang T.T.; CD59 receptor targeted delivery of miRNA-1284 and cisplatin-loaded liposomes for effective therapeutic efficacy against cervical cancer cells. AMB Express 2020,10(1),54", "ArticleIdList": ["10.1186/s13568-020-00990-z", "32185543"]}, {"Citation": "M\u00e1rquez M.G.; Dotson R.; Pias S.; Frolova L.V.; Tartis M.S.; Phospholipid prodrug conjugates of insoluble chemotherapeutic agents for ultrasound targeted drug delivery. Nanotheranostics 2020,4(1),40-56", "ArticleIdList": ["10.7150/ntno.37738", "31911893"]}, {"Citation": "Singh P.; Choudhury S.; Kulanthaivel S.; Bagchi D.; Banerjee I.; Ahmed S.A.; Pal S.K.; Photo-triggered destabilization of nanoscopic vehicles by dihydroindolizine for enhanced anticancer drug delivery in cervical carcinoma. Colloids Surf B Biointerfaces 2018,162,202-211", "ArticleIdList": ["10.1016/j.colsurfb.2017.11.035", "29195229"]}, {"Citation": "Shariare M.H.; Khan M.A.; Al-Masum A.; Khan J.H.; Uddin J.; Kazi M.; Development of stable liposomal drug delivery system of thymoquinone and its in vitro anticancer studies using breast cancer and cervical cancer cell lines. Molecules 2022,27(19),6744", "ArticleIdList": ["10.3390/molecules27196744", "36235288"]}, {"Citation": "Parveen S.; Kumar S.; Pal S.; Yadav N.P.; Rajawat J.; Banerjee M.; Enhanced therapeutic efficacy of Piperlongumine for cancer treatment using nano-liposomes mediated delivery. Int J Pharm 2023,643,123212", "ArticleIdList": ["10.1016/j.ijpharm.2023.123212", "37429561"]}, {"Citation": "Adeyemi S.A.; Az-Zamakhshariy Z.; Choonara Y.E.; In vitro prototyping of a nano-organogel for thermo-sonic intra-cervical delivery of 5-fluorouracil-loaded solid lipid nanoparticles for cervical cancer. AAPS PharmSciTech 2023,24(5),123", "ArticleIdList": ["10.1208/s12249-023-02583-y", "37226039"]}, {"Citation": "Eslamian F.; Keshtmand Z.; Hesampour A.; Preparation of Artemisia turcomanic encapsulated niosomal nanocarriers and evaluation of anticancer activities and apoptosis gene expression analysis in hela cells. Chem Biodivers 2023,20(5),e202201160", "ArticleIdList": ["10.1002/cbdv.202201160", "37026601"]}, {"Citation": "Solanki R.; Jangid A.K.; Jadav M.; Kulhari H.; Patel S.; Folate functionalized and evodiamine-loaded pluronic nanomicelles for augmented cervical cancer cell killing. Macromol Biosci 2023,23(9),2300077", "ArticleIdList": ["10.1002/mabi.202300077", "37163974"]}, {"Citation": "Liao J.; Peng H.; Wei X.; Song Y.; Liu C.; Li D.; Yin Y.; Xiong X.; Zheng H.; Wang Q.; A bio-responsive 6-mercaptopurine/doxorubicin based \u201cClick Chemistry\u201d polymeric prodrug for cancer therapy. Mater Sci Eng C 2020,108,110461", "ArticleIdList": ["10.1016/j.msec.2019.110461", "31924029"]}, {"Citation": "Frank L.A.; Gazzi R.P.; Mello P.A.; Chaves P.; Pe\u00f1a F.; Beck R.C.R.; Buffon A.; Pohlmann A.R.; Guterres S.S.; Anti-HPV nanoemulsified-imiquimod: A new and potent formulation to treat cervical cancer. AAPS PharmSciTech 2020,21(2),54", "ArticleIdList": ["10.1208/s12249-019-1558-x", "31907712"]}, {"Citation": "AlMotwaa S.M.; Coupling Ifosfamide to nanoemulsion-based clove oil enhances its toxicity on malignant breast cancer and cervical cancer cells. Pharmacia 2021,68(4),779-787", "ArticleIdList": ["10.3897/pharmacia.68.e68291"]}, {"Citation": "Periasamy V.S.; Subash-Babu P.; Muthukumaran V.R.; Akbarsha M.A.; Alshatwi A.A.; In vitro cytotoxic effect of formulated semecarpus ghee nanoemulsion on human cervical cancer (SiHa) cells. Adv Sci Lett 2012,6(1),75-79", "ArticleIdList": ["10.1166/asl.2012.2037"]}, {"Citation": "Saffari I; Motallebi Moghanjoghi A; Sharafati Chaleshtori R; Ataee M; Khaledi A.; Nanoemulsification of rose (Rosa damascena) essential oil: Characterization, anti-Salmonella, in vitro cytotoxicity to cancer cells, and advantages in sheep meat application. J Food Qual 2023,2023,1-15"}, {"Citation": "De Matos RPA; Calmon MF; Amantino CF; Effect of curcumin-nanoemulsion associated with photodynamic therapy in cervical carcinoma cell lines. Biomed Res Int 2018,2018,4057959", "ArticleIdList": ["10.1155/2018/4057959"]}, {"Citation": "Banerjee S.L.; Khamrai M.; Sarkar K.; Singha N.K.; Kundu P.P.; Modified chitosan encapsulated core-shell Ag Nps for superior antimicrobial and anticancer activity. Int J Biol Macromol 2016,85,157-167", "ArticleIdList": ["10.1016/j.ijbiomac.2015.12.068", "26724687"]}, {"Citation": "Mousavi S.B.S.; Dehpour H.A; Farkhande P.; Effects of cytotoxicity of nanoparticles of Ag/Si_O_P/Gelatin on uterus cancer cell lines. Anim Biol J 2015,7(3),67-72"}, {"Citation": "Thomas S.; Gunasangkaran G.; Arumugam V.A.; Muthukrishnan S.; Synthesis and characterization of zinc oxide nanoparticles of Solanum nigrum and its anticancer activity via the induction of apoptosis in cervical cancer. Biol Trace Elem Res 2022,200(6),2684-2697", "ArticleIdList": ["10.1007/s12011-021-02898-6", "34448982"]}, {"Citation": "Svenningsen S.W.; Janaszewska A.; Ficker M.; Petersen J.F.; Klajnert-Maculewicz B.; Christensen J.B.; Two for the price of one: PAMAM-dendrimers with mixed Phosphoryl choline and oligomeric poly (caprolactone) surfaces. Bioconjug Chem 2016,27(6),1547-1557", "ArticleIdList": ["10.1021/acs.bioconjchem.6b00213", "27244598"]}, {"Citation": "Luong D.; Kesharwani P.; Killinger B.A.; Moszczynska A.; Sarkar F.H.; Padhye S.; Rishi A.K.; Iyer A.K.; Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures. J Colloid Interface Sci 2016,484,33-43", "ArticleIdList": ["10.1016/j.jcis.2016.08.061", "27585998"]}, {"Citation": "Lee S.R.; Kim Y.J.; Hydrophilic chlorin e6-poly (amidoamine) dendrimer nanoconjugates for enhanced photodynamic therapy. Nanomaterials 2018,8(6),445", "ArticleIdList": ["10.3390/nano8060445", "29912159"]}, {"Citation": "Yadav N.; Tripathi A.; Parveen A.; Parveen S.; Banerjee M.; PLGA- quercetin nano-formulation inhibits cancer progression via mitochondrial dependent caspase-3, 7 and independent FoxO1 activation with concomitant PI3K/AKT suppression. Pharmaceutics 2022,14(7),1326", "ArticleIdList": ["10.3390/pharmaceutics14071326", "35890222"]}, {"Citation": "Kavya K.V.; Vargheese S.; Shukla S.; Khan I.; Dey D.K.; Bajpai V.K.; Thangavelu K.; Vivek R.; Kumar R.T.R.; Han Y.K.; Huh Y.S.; Haldorai Y.; A cationic amino acid polymer nanocarrier synthesized in supercritical CO for co-delivery of drug and gene to cervical cancer cells. Colloids Surf B Biointerfaces 2022,216,112584", "ArticleIdList": ["10.1016/j.colsurfb.2022.112584", "35617878"]}, {"Citation": "Liao J.; Zheng H.; Hu R.; Cao J.; Wei X.; Li D.; Zheng H.; Yin Y.; Hyaluronan based tumor-targeting and pH-responsive shell cross-linkable nanoparticles for the controlled release of doxorubicin. J Biomed Nanotechnol 2018,14(3),496-509", "ArticleIdList": ["10.1166/jbn.2018.2510", "29663922"]}, {"Citation": "Saha B.; Choudhury N.; Seal S.; Ruidas B.; De P.; Aromatic nitrogen mustard-based autofluorescent amphiphilic brush copolymer as ph-responsive drug delivery vehicle. Biomacromolecules 2019,20(1),546-557", "ArticleIdList": ["10.1021/acs.biomac.8b01468", "30521313"]}, {"Citation": "Frank L.A.; Gazzi R.P.; de Andrade Mello P.; Buffon A.; Pohlmann A.R.; Guterres S.S.; Imiquimod-loaded nanocapsules improve cytotoxicity in cervical cancer cell line. Eur J Pharm Biopharm 2019,136,9-17", "ArticleIdList": ["10.1016/j.ejpb.2019.01.001", "30630060"]}, {"Citation": "Fong P; Cheong C; Mak K; Effects of cordycepin, gold nanostar, and their combination on endometrial cancer cells. Nat Prod Commun 2020,15(8),1934578X20946939"}, {"Citation": "Zhu B.; Xie N.; Yue L.; Wang K.; Bani-Fwaz M.Z.; Hussein Osman H-E.; El-kott A.F.; Bai X.; Formulation and characterization of a novel anti-human endometrial cancer supplement by gold nanoparticles green-synthesized using Spinacia oleracea L. leaf aqueous extract. Arab J Chem 2022,15(3),103576", "ArticleIdList": ["10.1016/j.arabjc.2021.103576"]}, {"Citation": "Taghavi F.; Saljooghi A.S.; Gholizadeh M.; Ramezani M.; Deferasirox-coated iron oxide nanoparticles as a potential cytotoxic agent. MedChemComm 2016,7(12),2290-2298", "ArticleIdList": ["10.1039/C6MD00293E"]}, {"Citation": "Gong X.; Pu X.; Wang J.; Yang L.; Cui Y.; Li L.; Sun X.; Liu J.; Bai J.; Wang Y.; Enhancing of nanocatalyst-driven chemodynaminc therapy for endometrial cancer cells through inhibition of PINK1/Parkin-mediated mitophagy. Int J Nanomed 2021,16,6661-6679", "ArticleIdList": ["10.2147/IJN.S329341", "34616150"]}, {"Citation": "Edwards K.; Yao S.; Pisano S.; Feltracco V.; Brusehafer K.; Samanta S.; Oommen O.P.; Gazze S.A.; Paravati R.; Maddison H.; Li C.; Gonzalez D.; Conlan R.S.; Francis L.; Hyaluronic acid-functionalized nanomicelles enhance SAHA efficacy in 3D endometrial cancer models. Cancers 2021,13(16),4032", "ArticleIdList": ["10.3390/cancers13164032", "34439185"]}, {"Citation": "Song G.; Cheng L.; Chao Y.; Yang K.; Liu Z.; Emerging nanotechnology and advanced materials for cancer radiation therapy. Adv Mater 2017,29(32),1700996", "ArticleIdList": ["10.1002/adma.201700996", "28643452"]}, {"Citation": "Bergs J.W.; Wacker M.G.; Hehlgans S.; Piiper A.; Multhoff G.; R\u00f6del C.; R\u00f6del F.; The role of recent nanotechnology in enhancing the efficacy of radiation therapy. Biochim Biophys Acta 2015,1856(1),130-143", "ArticleIdList": ["26142869"]}, {"Citation": "Geng F.; Song K.; Xing J.Z.; Yuan C.; Yan S.; Yang Q.; Chen J.; Kong B.; Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer. Nanotechnology 2011,22(28),285101", "ArticleIdList": ["10.1088/0957-4484/22/28/285101", "21654036"]}, {"Citation": "Yallapu M.M.; Maher D.M.; Sundram V.; Bell M.C.; Jaggi M.; Chauhan S.C.; Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res 2010,3(1),11", "ArticleIdList": ["10.1186/1757-2215-3-11", "20429876"]}, {"Citation": "Hu R.; Zheng M.; Wu J.; Li C.; Shen D.; Yang D.; Li L.; Ge M.; Chang Z.; Dong W.; Core-shell magnetic gold nanoparticles for magnetic field-enhanced radio-photothermal therapy in cervical cancer. Nanomaterials 2017,7(5),111", "ArticleIdList": ["10.3390/nano7050111", "28492507"]}, {"Citation": "Maury P.; Mondini M.; Chargari C.; Darricau A.; Shahin M.; Ammari S.; Bockel S.; Genestie C.; Wu T.D.; Lux F.; Tillement O.; Lacombe S.; Deutsch E.; Robert C.; Porcel E.; Clinical transfer of AGuIX\u00ae-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework. Nanomedicine 2023,50,102676", "ArticleIdList": ["10.1016/j.nano.2023.102676", "37084803"]}, {"Citation": "Geng F.; Xing J.Z.; Chen J.; Yang R.; Hao Y.; Song K.; Kong B.; Pegylated glucose gold nanoparticles for improved in-vivo bio-distribution and enhanced radiotherapy on cervical cancer. J Biomed Nanotechnol 2014,10(7),1205-1216", "ArticleIdList": ["10.1166/jbn.2014.1855", "24804541"]}, {"Citation": "Zhang X.D.; Chen J.; Min Y.; Park G.B.; Shen X.; Song S.S.; Sun Y-M.; Wang H.; Long W.; Xie J.; Gao K.; Zhang L.; Fan S.; Fan F.; Jeong U.; Metabolizable Bi2Se3 nanoplates: Biodistribution, toxicity, and uses for cancer radiation therapy and imaging. Adv Funct Mater 2014,24(12),1718-1729", "ArticleIdList": ["10.1002/adfm.201302312"]}, {"Citation": "Sztandera K.; Gorzkiewicz M.; Klajnert-Maculewicz B.; Gold nanoparticles in cancer treatment. Mol Pharm 2019,16(1),1-23", "ArticleIdList": ["10.1021/acs.molpharmaceut.8b00810", "30452861"]}, {"Citation": "Aguilar-P\u00e9rez K.M.; Avil\u00e9s-Castrillo J.I.; Ruiz-Pulido G.; Medina D.I.; Parra-Saldivar R.; Iqbal H.M.N.; Nanoadsorbents in focus for the remediation of environmentally-related contaminants with rising toxicity concerns. Sci Total Environ 2021,779,146465", "ArticleIdList": ["10.1016/j.scitotenv.2021.146465", "34030232"]}, {"Citation": "Muthu M.S.; Feng S-S.; Theranostic liposomes for cancer diagnosis and treatment: Current development and pre-clinical success 2013,151-155"}, {"Citation": "Rasool M.; Malik A.; Waquar S.; Arooj M.; Zahid S.; Asif M.; Shaheen S.; Hussain A.; Ullah H.; Gan S.H.; New challenges in the use of nanomedicine in cancer therapy. Bioengineered 2022,13(1),759-773", "ArticleIdList": ["10.1080/21655979.2021.2012907", "34856849"]}, {"Citation": "Gurunathan S.; Qasim M.; Park C.H.; Arsalan Iqbal M.; Yoo H.; Hwang J.H.; Uhm S.J.; Song H.; Park C.; Choi Y.; Kim J.H.; Hong K.; Cytotoxicity and transcriptomic analyses of biogenic palladium nanoparticles in human ovarian cancer cells (SKOV3). Nanomaterials 2019,9(5),787", "ArticleIdList": ["10.3390/nano9050787", "31121951"]}, {"Citation": "Yuan Y-G; Zhang S; Hwang J-Y; Kong I-K; Silver nanoparticles potentiates cytotoxicity and apoptotic potential of camptothecin in human cervical cancer cells. Oxid Med Cell Longev 2018,2018,6121328", "ArticleIdList": ["10.1155/2018/6121328"]}, {"Citation": "Baharara J.; Ramezani T.; Divsalar A.; Mousavi M.; Seyedarabi A.; Induction of apoptosis by green synthesized gold nanoparticles through activation of caspase-3 and 9 in human cervical cancer cells. Avicenna J Med Biotechnol 2016,8(2),75-83", "ArticleIdList": ["27141266"]}, {"Citation": "Mills K.A.; Quinn J.M.; Roach S.T.; Palisoul M.; Nguyen M.; Noia H.; Guo L.; Fazal J.; Mutch D.G.; Wickline S.A.; Pan H.; Fuh K.C.; p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts. Sci Rep 2019,9(1),4762", "ArticleIdList": ["10.1038/s41598-019-41122-3", "30886159"]}, {"Citation": "Medina-Guti\u00e9rrez E.; Garc\u00eda-Le\u00f3n A.; Gallardo A.; \u00c1lamo P.; Alba-Castell\u00f3n L.; Unzueta U.; Villaverde A.; V\u00e1zquez E.; Casanova I.; Mangues R.; Potent anticancer activity of CXCR4-targeted nanostructured toxins in aggressive endometrial cancer models. Cancers 2022,15(1),85", "ArticleIdList": ["10.3390/cancers15010085", "36612081"]}, {"Citation": "Lv Y.; Zou Y.; Yang L.; Uncertainty and sensitivity analysis of properties of phase change micro/nanoparticles for thermal protection during cryosurgery. Forsch Ingwes 2012,76(1-2),41-50", "ArticleIdList": ["10.1007/s10010-012-0153-z"]}, {"Citation": "Ryman-Rasmussen J.P.; Riviere J.E.; Monteiro-Riviere N.A.; Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 2006,91(1),159-165", "ArticleIdList": ["10.1093/toxsci/kfj122", "16443688"]}, {"Citation": "Kratz F.; A clinical update of using albumin as a drug vehicle - A commentary. J Control Release 2014,190,331-336", "ArticleIdList": ["10.1016/j.jconrel.2014.03.013", "24637463"]}, {"Citation": "Alberts D.S.; Blessing J.A.; Landrum L.M.; Warshal D.P.; Martin L.P.; Rose S.L.; Bonebrake A.J.; Ramondetta L.M.; Phase II trial of nab- paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study. Gynecol Oncol 2012,127(3),451-455", "ArticleIdList": ["10.1016/j.ygyno.2012.09.008", "22986144"]}, {"Citation": "Fu S.; Naing A.; Moulder S.L.; Culotta K.S.; Madoff D.C.; Ng C.S.; Madden T.L.; Falchook G.S.; Hong D.S.; Kurzrock R.; Phase I trial of hepatic arterial infusion of nanoparticle albumin-bound paclitaxel: Toxicity, pharmacokinetics, and activity. Mol Cancer Ther 2011,10(7),1300-1307", "ArticleIdList": ["10.1158/1535-7163.MCT-11-0259", "21571911"]}, {"Citation": "Jasrotia R.; Dhanjal D.S.; Bhardwaj S.; Sharma P.; Chopra C.; Singh R.; Kumar A.; Mubayi A.; Kumar D.; Kumar R.; Goyal A.; Nanotechnology based vaccines: Cervical cancer management and perspectives. J Drug Deliv Sci Technol 2022,71,103351", "ArticleIdList": ["10.1016/j.jddst.2022.103351"]}, {"Citation": "Kour S.; Biswas I.; Sheoran S.; Arora S.; Sheela P.; Duppala S.K.; Murthy D.K.; Pawar S.C.; Singh H.; Kumar D.; Prabhu D.; Vuree S.; Kumar R.; Artificial intelligence and nanotechnology for cervical cancer treatment: Current status and future perspectives. J Drug Deliv Sci Technol 2023,83,104392", "ArticleIdList": ["10.1016/j.jddst.2023.104392"]}, {"Citation": "Zafar A.; Alruwaili N.K.; Imam S.S.; Alharbi K.S.; Afzal M.; Alotaibi N.H.; Yasir M.; Elmowafy M.; Alshehri S.; Novel nanotechnology approaches for diagnosis and therapy of breast, ovarian and cervical cancer in female: A review. J Drug Deliv Sci Technol 2021,61,102198", "ArticleIdList": ["10.1016/j.jddst.2020.102198"]}]}], "History": [{"Year": "2023", "Month": "11", "Day": "8"}, {"Year": "2024", "Month": "2", "Day": "20"}, {"Year": "2024", "Month": "6", "Day": "20", "Hour": "6", "Minute": "41"}, {"Year": "2024", "Month": "3", "Day": "19", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "3", "Day": "19", "Hour": "1", "Minute": "43"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38500284", "10.2174/0113816128291955240306112558", "CPD-EPUB-139240"]}}]}